PAVmed And Lucid Chairman And Chief Executive Officer, Dr. Lishan Aklog, Testifies At U.S. House Of Representatives Energy And Commerce Committee, Hearing On Life-Saving Innovations And Medicare Coverage
Portfolio Pulse from Happy Mohamed
Dr. Lishan Aklog, CEO of PAVmed Inc. (NASDAQ:PAVM) and Lucid Diagnostics Inc. (NASDAQ:LUCD), testified at the U.S. House of Representatives Energy and Commerce Committee, advocating for stronger transparency and predictability in federal proposals to improve access to innovative technologies. He highlighted the potential of Lucid's EsoGuard Esophageal DNA Test in early detection of esophageal cancer.
July 19, 2023 | 1:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Lucid Diagnostics' EsoGuard Esophageal DNA Test was highlighted in the CEO's testimony at the U.S. House Committee, which could potentially increase its visibility and adoption.
The CEO's testimony highlighted the potential of Lucid's EsoGuard Test, which could increase its visibility and adoption, potentially leading to increased revenues.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEUTRAL IMPACT
PAVmed's CEO's testimony at the U.S. House Committee could potentially influence federal proposals, which may impact the company's future operations.
The CEO's testimony could potentially influence federal proposals, which may impact the company's future operations and market position.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80